MedTrace Logo

EFFects of EXPosure and Cognitive-behavioural Therapy for Chronic BACK Pain

NCT05294081 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2025-05-20

No results posted yet for this study

Summary

The overall aim of the present study is to compare two different psychological methods, Cognitive Behavioural Therapy (CBT) and Graduated Exposure in vivo (EXP) in the treatment of chronic back pain with regard to effectiveness and improvement of pain related disability.

Exploratory research will also be conducted to identify predictors of which patient groups benefit more from which method. This should optimise treatment options and create effective treatment offers for subgroups of pain patients.

Exposure therapy is an effective and economical treatment modality and was shown in a previous pilot study to be superior to CBT in reducing perceived movement limitation. CBT, on the other hand, appeared to be more effective in establishing coping strategies. With the help of the current study it should be possible to compare the effectiveness of both treatment methods and, in perspective, to identify those patient groups that benefit from exposure therapy and thus create a tailor-made treatment programme for subgroups of pain patients.

A total of 380 patients (age: ≥ 18) with chronic back pain and a sufficient degree of impairment will be included and analysed in the study.

Conditions

  • Chronic Low Back Pain

Interventions

BEHAVIORAL

Exposure therapy

10 sessions based on an individualized pain hierarchy

BEHAVIORAL

Cognitive behavioral therapy

10 sessions with graded activity, relaxations techniques and cognitive interventions

Sponsors & Collaborators

  • Heidelberg University

    collaborator OTHER

  • University of Kaiserslautern-Landau

    lead OTHER

Principal Investigators

  • Julia A Glombiewski, Prof. Dr. · RPTU Kaiserslautern - Landau, Department of Clinical Psychology and Psychotherapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2025-10-31
Completion
2027-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05294081 on ClinicalTrials.gov